Oncology
ASCO 2023 – Dr Lalan Wilfong
In the last video from ASCO 2023, we step away from the R&D side to talk about drug costs and payment models.
Oncology
ASCO 2023 – Jaydev Thakkar
In our penultimate video from ASCO 2023, editor-in-chief Jonah Comstock touches base with Biofourmis chief operating officer Jaydev Thakkar.
Oncology
ASCO 2023 – Mark Reisenauer
As we approach the last of our exclusive coverage of ASCO 2023, editor-in-chief Jonah Comstock speaks with Mark Reisenauer, president of US commercial at Astellas.
Oncology
ASCO 2023 – Warner Biddle
While ASCO 2023 didn’t have too much focus on cell therapies, because of their lack of impact so far on the solid tumour space, Kite, a Gilead company, did share new data on Yescarta for la
Oncology
ASCO 2023 – Jennifer Elliott
Some of the most impactful news out of ASCO 2023 dealt with new treatments for patients with few options in the status quo of cancer care.
Editor's Picks
Editor's Picks
